anmelden
NASDAQ Composite Index
25.739,64
PKT
-300,39
PKT
-1,15
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NASDAQ Composite Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 26.06.12 | Teva Pharmaceutical Industries outperform | Exane-BNP Paribas SA | |
| 26.06.12 | Microsoft buy | Sarasin Research | |
| 26.06.12 | BlackBerry sector perform | Scotia Capital Markets | |
| 26.06.12 | Teva Pharmaceutical Industries hold | Jefferies & Company Inc. | |
| 26.06.12 | Teva Pharmaceutical Industries outperform | RBC Capital Markets | |
| 26.06.12 | BlackBerry reduce | GMP Securities | |
| 26.06.12 | QUALCOMM outperform | Sanford C. Bernstein and Co., Inc. | |
| 26.06.12 | Amazon buy | Banc of America Securities-Merrill Lynch | |
| 25.06.12 | Volvo (B) neutral | Goldman Sachs Group Inc. | |
| 25.06.12 | Alphabet A (ex Google) buy | Citigroup Corp. | |
| 25.06.12 | Teva Pharmaceutical Industries buy | UBS AG | |
| 25.06.12 | Teva Pharmaceutical Industries equal-weight | Morgan Stanley | |
| 25.06.12 | Baidu.com perform | Oppenheimer & Co. Inc. | |
| 25.06.12 | Electronic Arts neutral | Citigroup Corp. | |
| 22.06.12 | NetApp sector perform | RBC Capital Markets | |
| 22.06.12 | Apple buy | Jefferies & Company Inc. | |
| 22.06.12 | Gilead Sciences outperform | RBC Capital Markets | |
| 22.06.12 | Bed Bath Beyond overweight | Barclays Capital | |
| 22.06.12 | Amazon halten | Der Aktionärsbrief | |
| 22.06.12 | Biomarin Pharmaceutical outperform | RBC Capital Markets | |
| 22.06.12 | Microsoft halten | Der Aktionärsbrief | |
| 22.06.12 | Visa buy | Goldman Sachs Group Inc. | |
| 22.06.12 | Microsoft outperform | Sanford C. Bernstein and Co., Inc. | |
| 22.06.12 | Starbucks overweight | Piper Jaffray & Co. | |
| 21.06.12 | Bed Bath Beyond outperform | Oppenheimer & Co. Inc. | |
| 21.06.12 | SKF Group (B, Fria) buy | Goldman Sachs Group Inc. | |
| 21.06.12 | Adobe sector perform | RBC Capital Markets | |
| 21.06.12 | Oracle buy | UBS AG | |
| 21.06.12 | Amgen neutral | Credit Suisse Group | |
| 21.06.12 | Bed Bath Beyond neutral | UBS AG | |
| 21.06.12 | Apple overweight | Barclays Capital | |
| 21.06.12 | Adobe neutral | Credit Suisse Group | |
| 21.06.12 | Microsoft buy | Nomura | |
| 21.06.12 | Microsoft buy | Deutsche Bank Securities | |
| 21.06.12 | Autodesk sector perform | RBC Capital Markets | |
| 21.06.12 | Apple strong buy | Raymond James Financial, Inc. | |
| 21.06.12 | Applied Materials overweight | Barclays Capital | |
| 21.06.12 | Neurocrine Biosciences buy | ROTH Capital Partners, LLC | |
| 21.06.12 | Applied Materials buy | Stifel, Nicolaus & Co., Inc. | |
| 21.06.12 | Adobe buy | Stifel, Nicolaus & Co., Inc. |